Global Bio-Isoprene Market Strategic Research Report

Scope of the Report

In 2024, global Bio-Isoprene capacity 1600 Kg, sales reached approximately 1489 Kg, with an average market price of around 3 USD/Kg, industrial gross margin 31%.

Bio-Isoprene refers to isoprene produced from bio-based feedstocks via bioprocesses and used to make polyisoprene (IR), SIS, and other elastomers for tires, medical gloves, adhesives, and sealants—positioned as a drop-in alternative to petro-isoprene. For Bio-Isoprene, headline specifications mirror polymer-grade monomer requirements: high purity (typically ≥99%), controlled inhibitor (e.g., TBC), and ultra-low trace impurities (cyclopentadiene, sulfur species, acetylenes, carbonyls, etc.) that otherwise poison polymerization catalysts and jeopardize high-cis microstructure and molecular-weight control; fermentation-to-distillation trains, inhibitor management, and stability protocols are engineered to match or exceed petro baselines. Technically, Bio-Isoprene relies on engineered microbes (E. coli/yeast) implementing MVA or MEP pathways and an isoprene synthase (IspS), with emerging routes converting lignocellulose, crude glycerol (biodiesel by-product), or recycled carbon/CO-rich gases into Bio-Isoprene. The ecosystem includes early BioIsoprene demonstrations from Goodyear with DuPont Industrial Biosciences (Genencor); a Braskem-Amyris-Michelin collaboration on renewable isoprene; Visolis partnerships with Goodyear (2023) and Zeon (2024) on bio-isoprene from lignocellulosics/biobased inputs; LanzaTech with Sumitomo Riko to derive isoprene from rubber/resin wastes; and Japan-based players (Zeon, Yokohama) advancing bio-isoprene R&D and facilities. From a status standpoint, Bio-Isoprene is converging on “drop-in” monomer quality while moving through customer co-validation on existing polymerization and compounding lines. As a recent concrete deal case, Zeon and Visolis signed an MoU on Mar 30, 2024 to advance commercialization of bio-isoprene monomer—showing the “materials company × synbio startup × downstream validation” loop that underpins Bio-Isoprene scale-up.

Bio-Isoprene is trending toward end-to-end decarbonization, multi-feedstock optionality, petro-equivalency in polymerization, compliance stringency, and localized co-development: LCA targets push carbon-efficient fermentation, lower-energy distillation, and tuned inhibitor packages; lignocellulosics/crude glycerol/recycled-carbon routes diversify away from food-grade sugars; “equivalency” across monomer-to-polymer-to-formulation is a gating criterion with tighter specs on catalyst-sensitive impurities; medical/healthcare raises traceability and residuals control; and co-located or near-customer assets in North America/Japan/SE Asia compress logistics and qualification cycles for Bio-Isoprene.

This report presents a comprehensive overview of the global Bio-Isoprene market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Sucrose etc Sugar Feedstock
• Lignocellulosic Feedstock
• Others

Segment by Process

• Microbial Fermentation
• Recycling Method

Segment by Purity

• 100%
• Below 100%

Segment by Application

• Tires
• Adhesives and Sealants
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Bio-Isoprene market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Tires, Adhesives and Sealants, Others evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact